Pages that link to "Q40770822"
Jump to navigation
Jump to search
The following pages link to Mechanisms of hormone resistance in breast cancer (Q40770822):
Displaying 38 items.
- Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells (Q24314806) (← links)
- Identification of a novel breast-cancer-anti-estrogen-resistance (BCAR2) locus by cell-fusion-mediated gene transfer in human breast-cancer cells (Q28246373) (← links)
- Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence (Q28396413) (← links)
- Altering the estrogenic milieu of breast cancer with a focus on the new aromatase inhibitors (Q33871478) (← links)
- New generation aromatase inhibitors in breast cancer. Weighing out potential costs and benefits (Q34007012) (← links)
- Genetic mechanisms of estrogen-independence in breast cancer (Q34403755) (← links)
- Tamoxifen resistance in breast cancer: elucidating mechanisms (Q34427746) (← links)
- "Resurrection of clinical efficacy" after resistance to endocrine therapy in metastatic breast cancer (Q34973200) (← links)
- Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry. (Q35834174) (← links)
- Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer (Q36080684) (← links)
- Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer (Q36081930) (← links)
- Progesterone regulates the proliferation of breast cancer cells - in vitro evidence (Q36277982) (← links)
- Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth (Q36569036) (← links)
- Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. (Q36672230) (← links)
- Screening and characterization of estrogenic activity from a hydroxystilbene library (Q36893218) (← links)
- Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer (Q37144740) (← links)
- Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer (Q39491094) (← links)
- Thymine-rich single-stranded DNA activates Mcm4/6/7 helicase on Y-fork and bubble-like substrates (Q40240263) (← links)
- Flow cytometry: potential utility in monitoring drug effects in breast cancer (Q40568066) (← links)
- Insulin-like growth factors in breast cancer (Q41463854) (← links)
- Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer (Q42142801) (← links)
- Tamoxifen inhibits nitrobenzylthioinosine-sensitive equilibrative uridine transport in human MCF-7 breast cancer cells (Q42540015) (← links)
- High performance liquid chromatographic determination of 123-I labeled tamoxifen metabolites in human plasma (Q43588994) (← links)
- Deaths from breast cancer: tackling multidimensionality and non-linearity by correspondence analysis (Q43838221) (← links)
- Effect of phosphatidic acid on human breast cancer cells exposed to doxorubicin (Q43840233) (← links)
- Loss of heterozygosity at pseudoautosomal regions in human breast cancer and association with negative hormonal phenotype (Q44071038) (← links)
- Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease (Q44664467) (← links)
- Polyamine inhibition of estrogen receptor (ER) DNA-binding and ligand-binding functions (Q46082739) (← links)
- Hormone dependence of mammary tumors induced in rats by intraperitoneal NMU injection. (Q53448388) (← links)
- Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment. (Q54065301) (← links)
- Allelic loss on chromosome 9q is associated with lymph node metastasis of primary breast cancer. (Q55263007) (← links)
- Hormonal therapy of breast cancer (Q60357515) (← links)
- Two distinct commonly deleted regions on chromosome 13q suggest involvement of BRCA2 and retinoblastoma genes in sporadic breast carcinomas (Q71760922) (← links)
- Reduced tamoxifen accumulation is not associated with stimulated growth in tamoxifen resistance (Q72875667) (← links)
- Estrogen receptor variants ERdelta5 and ERdelta7 down-regulate wild-type estrogen receptor activity (Q73305002) (← links)
- Lack of relationship between the expression of hsp27 heat shock estrogen receptor-associated protein and estrogen receptor or progesterone receptor status in male breast carcinoma (Q73503412) (← links)
- Long-term inhibitory effects of a novel anti-estrogen on the growth of ZR-75-1 and MCF-7 human breast cancer tumors in nude mice (Q73939973) (← links)
- Tamoxifen aziridine binding to cytosolic proteins from human breast specimens is negatively associated with estrogen receptors, progesterone receptors, pS2, and cathepsin-D (Q77579571) (← links)